The Foundation Medical Partners team invests in innovation that meets the future needs of providers, payers, employers, and patients. Our strategy is focused on transformational technologies and services that enable value-based healthcare and leverage wireless, data and analytics technologies.

Proven Success, Top Tier Performance

Foundation Medical Partners is a team of proven healthcare technology venture capital investors known for delivering strategic industry resources, insight, and total commitment to the success of the entrepreneurs with whom they partner. Founded in 2001 and expanded in 2013, current and prior investments of the general partners and the firm collectively include CardioMEMS (St. Jude Medical), CardioNet, eBenX (ADP), Functional Neuromodulation, Humedica (Optum Analytics), Iora Health, Pharmetrics (IMS Health), Predilytics, Rise Health (Best Doctors), SynapDX, T2 Biosystems, and Valence Health.

Wide Network, Unparalleled Strategic Resources

Foundation Medical Partners draws on a wide network of specialized resources within the healthcare industry and academic medical environment. The enormous intellectual and experiential capacity made available to FMP and its portfolio companies through these relationships is unparalleled in healthcare venture capital. FMP leverages these relationships to full advantage in deal sourcing and due diligence, as well as in key company building activities, including:

  • Industry advisory board support
  • Development partnerships
  • Beta site testing
  • Clinical leadership
  • Financial and technical insight
  • Key reference customer development

While Foundation Medical Partners reaps important benefits from strategic partnerships with key partners, the firm maintains complete independence, operating as a traditional venture capital firm.